The ASCIA COVID-19 Vaccine FAQ, Position Statement and webpage www.allergy.org.au/members/covid-19 have been updated with the following publications:

• COVID-19 vaccination decision guide for women who are pregnant, breastfeeding, or planning pregnancy has been developed by the Australian Government and is available at https://www.health.gov.au/resources/publications/covid-19-vaccination-covid-19-vaccination-decision-guide-for-women-who-are-pregnant-breastfeeding-or-planning-pregnancy
• COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization (WAO) Anaphylaxis Committee has recently been published open access at www.worldallergyorganizationjournal.org/article/S1939-4551(21)00011-9/fulltext

The ASCIA COVID-19 Vaccine Position Statement has been updated to include the following wording:

• In Australia, notifications of adverse events following immunisation should be made through the usual reporting mechanisms. Refer also to the Reporting to immunisation registers section of the Australian Immunisation Handbook. https://www.health.gov.au/health-topics/immunisation/health-professionals/reporting-and-managing-adverse-vaccination-events
• In New Zealand, notifications of adverse events should be reported to the Centre for Adverse Reactions Monitoring (CARM) https://nzphvc.otago.ac.nz/reporting/